Vera Therapeutics
Latest round
- Series C
Last raised
- Jan 2021
Total raised
- $80M
Investors
- 9
About Vera Therapeutics
a Trucode Gene Repair, Inc. operates as a biotechnology company that develops novel therapeutics to develop new therapies. In January 2021, Vera Therapeutics, Inc. In 2021, Vera Therapeutics was acquired by NeuBase Therapeutics Inc. In May 2021, Vera Therapeutics, Inc.35 million shares at USD 11 per share. The company is trading on the Nasdaq Global Market under the ticker symbol VERA. Vera Therapeutics provides clinical research and development for the treatment of immunological and inflammatory diseases to enable patients in the treatment of IgA nephropathy (IgAN), which is a rare autoimmune disease. In addition, the company also develops and commercializes atacicept in all indications from Merck KGaA, Darmstadt, Germany, a leading science, and technology company. The company generates revenue by offering the developed therapies to pharmaceutical companies. In addition, the company also plans to scale its manufacturing capabilities and expand the therapeutic pipeline in immunologic and inflammatory diseases.
Who invested in Vera Therapeutics
9 investors across 1 round
See all investors in Vera Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Jan 19, 2021
Amount
$80M
Investors
Questions about Vera Therapeutics
Who invested in Vera Therapeutics?
Vera Therapeutics has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vera Therapeutics raised?
Vera Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Vera Therapeutics last raise money?
Vera Therapeutics's most recent round on record is a Series C, in Jan 2021.
What does Vera Therapeutics do?
Vera Therapeutics is a biotechnology company.
Where is Vera Therapeutics headquartered?
Vera Therapeutics is headquartered in South San Francisco, US.
Which VCs invest in companies like Vera Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Vera Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Vera Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.